Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
NewsIn the Know: Healthcare News for April 29, 2024 Tyler MasonApril 26, 2024 In the Know: Healthcare News for April 29, 2024
ArticlesFor the Record with J.R. Spiess, President and CEO, The 180 Group Tyler MasonApril 26, 2024 For the Record with J.R. Spiess, President and CEO, The 180 Group
NewsChildren’s Minnesota and Minnesota Epilepsy Group Receive Re-Accreditation as a Level 4 Epilepsy Center Tyler MasonApril 24, 2024 Children’s Minnesota and Minnesota Epilepsy Group Receive Re-Accreditation as a Level 4 Epilepsy Center
NewsCogwear Expands to St. Paul for R&D and Production of Brain Wearable Tyler MasonApril 23, 2024 Cogwear Expands to St. Paul for R&D and Production of Brain Wearable